Search
Cloperidone
go.drugbank.com/drugs/DB20327ExperimentalCloperidone is a small molecule drug. Cloperidone has a monoisotopic molecular weight of 398.15 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 InhibitorsMofarotene
go.drugbank.com/drugs/DB20333ExperimentalMofarotene is a small molecule drug. The usage of the INN stem '-arotene' in the name indicates that Mofarotene is a arotinoid derivative. Mofarotene has a monoisotopic molecular weight of 433.3 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesBurapitant
go.drugbank.com/drugs/DB20607ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1 (substance P) receptor antagonist. Burapitant has a monoisotopic molecular weight of 681.2 Da.
Nicardipine
go.drugbank.com/drugs/DB00622ApprovedInvestigationalA potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the ...
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesTestosterone
go.drugbank.com/drugs/DB00624ApprovedInvestigationalTestosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine...
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesNiacin
go.drugbank.com/drugs/DB00627ApprovedInvestigationalNutraceuticalNiacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.
Categories: Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2E1 InhibitorsClorazepic acid
go.drugbank.com/drugs/DB00628ApprovedIllicitClorazepic acid (clorazepate) is a water-soluble benzodiazepine with muscle-relaxant and anticonvulsant actions effective in the treatment of anxiety. Following administration, clorazepate is rapidly converted to nordiazepam (N-desmethyl...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesPrednisone
go.drugbank.com/drugs/DB00635ApprovedInvestigationalVet approvedA synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Prednisone was granted FDA approval on 21 February 1955.
Categories: P-glycoprotein inducers, P-glycoprotein inhibitorsProducts: Prednisone D/P, P- Pack Prednisone 20mg, 7- Day Tapering Dose PackClofibrate
go.drugbank.com/drugs/DB00636ApprovedWithdrawnA fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersSynonyms: Ethyl 2-(p-chlorophenoxy)isobutyrate, alpha-p-Chlorophenoxyisobutyryl ethyl esterPentazocine
go.drugbank.com/drugs/DB00652ApprovedVet approvedThe first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
International brands: Talwin PXCategories: P-glycoprotein substrates